Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Diagnosing and Reporting Primary Cutaneous Melanoma with Updates to AJCC Staging
Description
In this presentation by Dr. Michael Tetzloff from UCSF, the focus is on the diagnosis and reporting of primary cutaneous melanoma alongside updates to AJCC staging. Dr. Tetzloff highlights the methods used to diagnose melanoma, which primarily rely on histopathological analysis, while also discussing the utility of immunohistochemical stains and next-generation sequencing in challenging cases. He emphasizes the importance of providing pathologists with essential clinical information, such as patient demographics and lesion characteristics, to enhance diagnostic accuracy. The talk also covers how to report and stage melanoma effectively according to the AJCC's 8th edition, detailing critical parameters like Breslow thickness and ulceration, which are vital for risk stratification and prognosis. Dr. Tetzloff advocates for the integration of emerging techniques such as molecular studies to further refine the understanding and classification of melanoma. Through a case study, he demonstrates the application of these principles in practice, underlining the necessity of precise reporting for optimal patient care.
View moreConclusions
- Histopathology remains the primary method for diagnosing melanoma in most cases.
- Immunohistochemical studies, such as p16 and PRAME, are helpful adjuncts in distinguishing melanoma from nevi.
- Loss of p16 expression indicates potential melanoma due to chromosomal alterations.
- An elevated Ki-67 proliferation marker is more commonly associated with melanoma than nevi.
- Next-generation sequencing (NGS) has revolutionized the understanding of the genetic progression from nevus to melanoma.
- Genomic instability, identified through NGS, is a key factor that distinguishes melanoma from benign nevi.
- The 8th edition of AJCC staging criteria is now the standard for melanoma, focusing on Breslow thickness and ulceration as critical factors for risk assessment.
- Mitotic figures, although less critical in the 8th edition, still provide prognostic value in melanoma pathology reporting.
- Clinical features such as patient age, lesion size, and photographic documentation enhance the diagnostic process for melanoma.
- Accurate staging and reporting under the AJCC is vital for guiding treatment and understanding patient prognosis.
- J AM ACAD DERMATOI VOLUME 80, NUMBER 1
- Cancer 2001:91:983-91
- J Clin Oncol 27:6199-6206.
- Gershenwald JE et al. CA Journal Clinic. 2017. 67(6):472-492.
- Scolyer RA et al. Am J Surg Pathol. 2019. 43(10):1442-1444.
- N Engl J Med 2015;373:1926-36.